Andrew Davis is VP at IRONWOOD PHARMACEUTICALS INC (IRWD). They have made 7 open-market trades across 1 company since 2022, most recently 2024-11-18.
CIK 0001932525
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IRWD | 284,685 | $1.1M |
Shares reported on the most recent Form 4, priced at the 2024-11-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IRWD | SELL | 2024-11-18 | 2024-11-20 | $4.08 | $22K | +0.3% | +26.1% | -43.3% |
| IRWD | SELL | 2024-05-20 | 2024-05-22 | $6.45 | $293K | +0.5% | -6.2% | -26.5% |
| IRWD | SELL | 2024-02-12 | 2024-02-14 | $15.24 | $300K | +4.1% | -38.1% | -54.5% |
| IRWD | SELL | 2023-11-20 | 2023-11-22 | $9.69 | $32K | +10.1% | +18.9% | +57.8% |
| IRWD | SELL | 2023-05-22 | 2023-05-24 | $10.12 | $128K | +4.7% | +1.6% | -13.0% |
| IRWD | SELL | 2023-02-27 | 2023-03-01 | $11.36 | $41K | -7.8% | -7.5% | -5.5% |
| IRWD | SELL | 2022-11-21 | 2022-11-23 | $11.56 | $39K | +3.2% | +7.3% | +0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.